EPIRUS BIOPHARMACEUTICALS IN - COM (EPRSQ)

CUSIP: 29428P107

Q1 2015 13F Holders as of 31 Mar 2015

Type / Class
Equity / COM
Total 13F shares
13,448,067
Share change
+10,412,851
Total reported value
$120,415,000
Price per share
$8.95
Number of holders
41
Value change
+$93,386,700
Number of buys
38
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 29428P107?
CUSIP 29428P107 identifies EPRSQ - EPIRUS BIOPHARMACEUTICALS IN - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of EPIRUS BIOPHARMACEUTICALS IN - COM (EPRSQ) as of Q1 2015

As of 31 Mar 2015, EPIRUS BIOPHARMACEUTICALS IN - COM (EPRSQ) was held by 41 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 13,448,067 shares. The largest 10 holders included JENNISON ASSOCIATES LLC, TPG Group Holdings (SBS) Advisors, Inc., Camber Capital Management LLC, Consonance Capital Management LP, FMR LLC, Cormorant Asset Management, LLC, Broadfin Capital, LLC, ADAGE CAPITAL PARTNERS GP LLC, VANGUARD GROUP INC, and Lombard Odier Asset Management (USA) Corp. This page lists 41 institutional shareholders reporting positions in this security for the Q1 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.